Clean Yield Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $192K | Sell |
6,823
-2,033
| -23% | -$54.1K | 0.05% | 139 |
|
|
2025
Q4 | $221K | Sell |
8,856
-562
| -6% | -$14.2K | 0.06% | 130 |
|
|
2025
Q3 | $240K | Buy |
9,418
+150
| +2% | +$3.7K | 0.07% | 122 |
|
|
2025
Q2 | $225K | Sell |
9,268
-970
| -9% | -$22.6K | 0.07% | 124 |
|
|
2025
Q1 | $259K | Sell |
10,238
-3,666
| -26% | -$95.9K | 0.08% | 113 |
|
|
2024
Q4 | $369K | Sell |
13,904
-265
| -2% | -$7.19K | 0.12% | 104 |
|
|
2024
Q3 | $410K | Sell |
14,169
-885
| -6% | -$25.8K | 0.13% | 98 |
|
|
2024
Q2 | $421K | Hold |
15,054
| – | – | 0.16% | 86 |
|
|
2024
Q1 | $418K | Sell |
15,054
-200
| -1% | -$5.55K | 0.16% | 85 |
|
|
2023
Q4 | $439K | Sell |
15,254
-379
| -2% | -$11.5K | 0.19% | 83 |
|
|
2023
Q3 | $518K | Buy |
15,633
+2,951
| +23% | +$104K | 0.23% | 72 |
|
|
2023
Q2 | $465K | Sell |
12,682
-238
| -2% | -$9.26K | 0.19% | 80 |
|
|
2023
Q1 | $527K | Sell |
12,920
-1,720
| -12% | -$74.3K | 0.22% | 76 |
|
|
2022
Q4 | $750K | Buy |
14,640
+628
| +4% | +$30.1K | 0.32% | 66 |
|
|
2022
Q3 | $613K | Buy |
14,012
+250
| +2% | +$12.1K | 0.28% | 74 |
|
|
2022
Q2 | $722K | Sell |
13,762
-270
| -2% | -$13.8K | 0.3% | 68 |
|
|
2022
Q1 | $726K | Sell |
14,032
-1,503
| -10% | -$78K | 0.26% | 78 |
|
|
2021
Q4 | $917K | Buy |
15,535
+205
| +1% | +$10.2K | 0.29% | 69 |
|
|
2021
Q3 | $659K | Buy |
15,330
+562
| +4% | +$24.9K | 0.22% | 81 |
|
|
2021
Q2 | $578K | Buy |
14,768
+606
| +4% | +$23.6K | 0.2% | 80 |
|
|
2021
Q1 | $513K | Sell |
14,162
-4,541
| -24% | -$161K | 0.19% | 81 |
|
|
2020
Q4 | $688K | Sell |
18,703
-1,719
| -8% | -$63.1K | 0.25% | 66 |
|
|
2020
Q3 | $711K | Sell |
20,422
-612
| -3% | -$21.5K | 0.29% | 55 |
|
|
2020
Q2 | $653K | Hold |
21,034
| – | – | 0.28% | 65 |
|
|
2020
Q1 | $651K | Sell |
21,034
-21,554
| -51% | -$734K | 0.31% | 59 |
|
|
2019
Q4 | $1.58M | Buy |
42,588
+2,908
| +7% | +$104K | 0.5% | 48 |
|
|
2019
Q3 | $1.35M | Sell |
39,680
-925
| -2% | -$33.6K | 0.45% | 51 |
|
|
2019
Q2 | $1.67M | Buy |
40,605
+1,034
| +3% | +$41.1K | 0.6% | 47 |
|
|
2019
Q1 | $1.59M | Sell |
39,571
-473
| -1% | -$18.9K | 0.65% | 47 |
|
|
2018
Q4 | $1.66M | Sell |
40,044
-27,807
| -41% | -$1.15M | 0.72% | 50 |
|
|
2018
Q3 | $2.84M | Buy |
67,851
+1,233
| +2% | +$47.5K | 1.13% | 37 |
|
|
2018
Q2 | $2.29M | Buy |
66,618
+658
| +1% | +$22.5K | 0.95% | 42 |
|
|
2018
Q1 | $2.22M | Buy |
65,960
+5,756
| +10% | +$198K | 0.94% | 43 |
|
|
2017
Q4 | $2.07M | Sell |
60,204
-712
| -1% | -$24.3K | 0.82% | 45 |
|
|
2017
Q3 | $2.06M | Hold |
60,916
| – | – | 0.84% | 43 |
|
|
2017
Q2 | $1.93M | Sell |
60,916
-286
| -0.5% | -$9.02K | 0.81% | 46 |
|
|
2017
Q1 | $1.99M | Buy |
61,202
+6,300
| +11% | +$199K | 0.84% | 42 |
|
|
2016
Q4 | $1.69M | Buy |
54,902
+285
| +0.5% | +$8.7K | 0.76% | 50 |
|
|
2016
Q3 | $1.75M | Buy |
54,617
+285
| +0.5% | +$9.53K | 0.76% | 47 |
|
|
2016
Q2 | $1.81M | Sell |
54,332
-105
| -0.2% | -$3.35K | 0.78% | 44 |
|
|
2016
Q1 | $1.68M | Sell |
54,437
-632
| -1% | -$18.1K | 0.75% | 50 |
|
|
2015
Q4 | $1.59M | Sell |
55,069
-158
| -0.3% | -$4.97K | 0.79% | 52 |
|
|
2015
Q3 | $1.86M | Sell |
55,227
-53
| -0.1% | -$1.7K | 0.88% | 46 |
|
|
2015
Q2 | $1.76M | Sell |
55,280
-375
| -0.7% | -$12.2K | 0.81% | 46 |
|
|
2015
Q1 | $1.84M | Buy |
55,655
+1,858
| +3% | +$59.1K | 0.79% | 47 |
|
|
2014
Q4 | $1.59M | Sell |
53,797
-158
| -0.3% | -$4.53K | 0.71% | 54 |
|
|
2014
Q3 | $1.51M | Hold |
53,955
| – | – | 0.73% | 54 |
|
|
2014
Q2 | $1.52M | Buy |
53,955
+1,764
| +3% | +$50.3K | 0.75% | 53 |
|
|
2014
Q1 | $1.59M | Hold |
52,191
| – | – | 0.82% | 51 |
|
|
2013
Q4 | $1.52M | Sell |
52,191
-214
| -0.4% | -$6.23K | 0.81% | 51 |
|
|
2013
Q3 | $1.43M | Hold |
52,405
| – | – | 0.77% | 49 |
|
|
2013
Q2 | $1.39M | Buy |
+52,405
| New | +$1.45M | 0.8% | 48 |
|
Other funds holding PFE
VCM
VPM
Clean Yield Group's PFE Position: Q1 2026 in Review
Clean Yield Group reduced its Pfizer (PFE) stake by 23% in Q1 2026, selling an estimated $54.1K and leaving 6,823 shares worth $192K. The position accounts for 0.05% of the portfolio, ranked #139.
Clean Yield Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.84M in Q3 2018. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Clean Yield Group held 6,823 shares of Pfizer worth $192K as of Q1 2026.
- Clean Yield Group sold 2,033 Pfizer shares in Q1 2026, an estimated $54.1K.
- Pfizer made up 0.05% of Clean Yield Group's portfolio in Q1 2026, its #139 holding.
- Clean Yield Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Clean Yield Group's Pfizer position peaked at $2.84M in Q3 2018.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.